#CNBC Madrigal Pharma CEO talks competition in the liver disease treatment space

Madrigal Pharma CEO talks competition in the liver disease treatment space
Bill Sibold, Madrigal Pharma CEO, joins ‘Fast Money’ to talk how Rezdiffra stacks up to competitors in the MASH treatment space, sales growth for the drug over the last year, and more.

Thank you for your support in keeping this website running.💛

View on “Tokyo Trend News”